Free Trial

Cambridge Investment Research Advisors Inc. Buys Shares of 95,728 Bowhead Specialty Holdings Inc. (NYSE:BOW)

Bowhead Specialty logo with Finance background

Cambridge Investment Research Advisors Inc. acquired a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 95,728 shares of the company's stock, valued at approximately $3,891,000. Cambridge Investment Research Advisors Inc. owned 0.29% of Bowhead Specialty as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Gallatin Point Capital LLC purchased a new position in shares of Bowhead Specialty in the fourth quarter worth about $389,599,000. Victory Capital Management Inc. boosted its holdings in Bowhead Specialty by 129.0% in the 4th quarter. Victory Capital Management Inc. now owns 1,508,003 shares of the company's stock worth $53,564,000 after buying an additional 849,408 shares during the period. American Century Companies Inc. grew its stake in Bowhead Specialty by 3.6% in the 4th quarter. American Century Companies Inc. now owns 953,549 shares of the company's stock valued at $33,870,000 after buying an additional 32,792 shares in the last quarter. Wasatch Advisors LP raised its holdings in Bowhead Specialty by 125.3% during the 4th quarter. Wasatch Advisors LP now owns 812,901 shares of the company's stock valued at $28,874,000 after acquiring an additional 452,033 shares during the period. Finally, Vanguard Group Inc. lifted its position in shares of Bowhead Specialty by 55.1% during the fourth quarter. Vanguard Group Inc. now owns 647,182 shares of the company's stock worth $22,988,000 after acquiring an additional 230,039 shares in the last quarter.

Bowhead Specialty Price Performance

NYSE:BOW traded down $0.98 during mid-day trading on Wednesday, hitting $35.75. 205,480 shares of the company's stock were exchanged, compared to its average volume of 202,978. The company has a market cap of $1.17 billion, a PE ratio of 27.22 and a beta of -0.61. Bowhead Specialty Holdings Inc. has a one year low of $24.41 and a one year high of $42.29. The business has a fifty day moving average price of $37.89 and a 200 day moving average price of $36.08.

Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.01. The business had revenue of $174.85 million during the quarter, compared to analysts' expectations of $105.17 million. Bowhead Specialty had a net margin of 9.32% and a return on equity of 12.52%. On average, equities analysts forecast that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

BOW has been the topic of several analyst reports. Morgan Stanley upped their price target on Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a research report on Monday, May 19th. Keefe, Bruyette & Woods increased their target price on shares of Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a research note on Friday, May 9th. JMP Securities raised their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. Piper Sandler began coverage on shares of Bowhead Specialty in a report on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 price target on the stock. Finally, JPMorgan Chase & Co. increased their price objective on Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 8th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Bowhead Specialty currently has a consensus rating of "Moderate Buy" and an average price target of $39.67.

View Our Latest Stock Analysis on Bowhead Specialty

Bowhead Specialty Company Profile

(Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

See Also

Institutional Ownership by Quarter for Bowhead Specialty (NYSE:BOW)

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines